Johanna Daily
About Johanna Daily
Johanna Patricia Daily, M.D., M.S. is an infectious disease specialist who is interested in the role of parasite biology in clinical disease. She has carried out translational studies in Africa for over ten years, to define parasite and host genetic associations with disease outcomes. In addition to basic research Dr. Daily has participated in studying malaria intervention outcomes with GHE resident Dr. Sievers in Rwanda. She completed her infectious disease fellowship at Brigham and Women's Hospital in Boston. She is presently an Associate Professor of Medicine at Albert Einstein College of Medicine with active collaborations in Malawi, Rwanda and Ethiopia.
Role(s) / Profession(s)
- Academic
- Physician
- Researcher
Organization
- Albert Einstein College of Medicine of Yeshiva University
- American Society of Tropical Medicine and Hygiene
Work Location(s)
- United States
Language(s)
- English
Johanna 's Communities
Recent Contributions
-
Johanna Daily replied to "INTRODUCTIONS" in the Malaria Treatment & Prevention community.
I have been with the malaria online community from the start. I am an Associate Professor of Medicine at Albert Einstein Medical College in New York. I have worked on drug resistance prevalence studies in Senegal (pfcrt, dhfr,dhps) and more recently am looking at parasite and host biology associated with ...
-
Johanna Daily replied to "Malaria resurgence: a systematic review and assessment of its causes" in the Malaria Treatment & Prevention community.
Violet- it does appear that mosquitoes may be changing their feeding pattern in response to IRS-no suprise that behavior that allows survival is selected for-see attached publication where in parts of Bioko Island, the Anopheles feed outdoors, which was not noted in studies years ago-best johanna
-
Johanna Daily replied to "Malaria Vaccine: What do you think?" in the Malaria Treatment & Prevention community.
This latest report mirrors earlier reports/results of this vaccine (some variation in adjuvant) Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 2004;364:1411-1420 Bejon P, Lusingu J, Olotu A, et al. Efficacy ...
-
Johanna Daily replied to "Should Quinine Be Used for Uncomplicated Malaria? Journal Watch" in the Malaria Treatment & Prevention community.
Agree with all the comments above: artesunate provides a survival advantage over quinine in severe disease; ACT are 1st line for mild disease for reasons noted; however quinine has been extremely effective against malaria, there is minimal reported resistance and multiple formulations for patients who cannot take oral meds; safe ...
-
Johanna Daily replied to "Injectable Treatments for Severe Malaria (original post by Vince Waite: 24 Oct 2010)" in the Malaria Treatment & Prevention community.
RE: loading dose of quinine This does seem to be the standard of care, and it used for drugs when a rapid theraputic level is needed (such as severe disease) as far as the evidence: there is a Cochrane Review: Cochrane Database Syst Rev. 2004;(3):CD003341. "High first dose quinine regimen ...
Recent Recommendations
- None at this time.